Global Pharmaceutical Packaging Industry to Record Growth with Rapid Expansion in the Global Pharmaceutical Industry

Add bookmark
Pharma IQ News
Pharma IQ News
02/07/2012


Pharmaceutical Packaging Industry, Revenue Forecasts, 2010–2017

Source: GBI Research, Company Annual Reports
The global pharmaceutical packaging market was valued at $47.8 billion in 2010. The market is forecast to grow at a compound annual growth rate (CAGR) of 7.3% from 2010–2017, to reach a value of $78 billion by 2017. The global pharmaceutical industry is currently registering rapid expansion, with advances in manufacturing processes, and technology innovation and integration, which are the main factors behind the growth of the pharmaceutical packaging industry globally. This growth is expected to be highest in the emerging economies of India and China, primarily on account of increasing generics and contract manufacturing activities in these countries.
 
Pharmaceutical Packaging Industry Will Overcome Challenges to Record High Growth Rates in the Future

Pharmaceutical Packaging Industry, Growth Drivers and Barriers, 2011
 
Source: GBI Research 
The pharmaceutical packaging industry will continue to grow as drugs worth $142 billion go off-patent in the next five years, expanding the generic market and the entire pharmaceutical packaging industry. The fastest growth in the pharmaceutical packaging market is expected to come from prefillable syringes and parenteral vials, which will continue to expand as advances in biotechnology lead to the introduction of new therapies that must be injected. The increasing demand for biologics will strengthen demand for innovative product packaging solutions in the global pharmaceutical packaging market.
 
All of these factors, along with the growing pharmaceutical industry, will continue to drive demand for packaging. However, the packaging industry will have to overcome challenges, such as the availability and price volatility of raw materials and changing health regulations, in order to meet increasing demand from the growing pharmaceutical industry.

Increasing Demand for Drug Delivery Devices and Blister Packaging Will Strengthen the Growth of the Pharmaceutical Packaging Industry

Plastic bottles emerged as the largest revenue generating segment for the pharmaceutical packaging industry in 2010, recording annual revenues of approximately $9.5 billion. This was closely followed by blister packaging and drug delivery devices, which generated revenues of $8.1 billion and $6.6 billion, respectively, in 2010. Other important segments in the pharmaceutical packaging industry were labels, accessories and other containers.
 
The market size of drug delivery devices and blister packaging is expected to grow at a faster rate than other segments in the pharmaceutical packaging industry. Increasing demand for improved drug delivery mechanisms and more complex biologic molecules will have to be complimented with better drug delivery devices. Products such as inhalers, nasal sprays, transdermal patches and oral ingestion containers have redefined the market and become as important as the drug itself. Also, blister packaging will record growth because of increasing usage of unit dose packaging. Some industry segments such as plastic bottles will register average growth, while others, such as glass bottles and containers, may record a decline in demand as they will be replaced by lightweight and cheap plastic products.
 [inlinead]
Developing Nations to Take Advantage of Increasing Demand for Pharmaceutical Packaging

The global pharmaceutical packaging market is dominated by the US, with a market share of 37% in 2010. This was followed by Western Europe and Asia Pacific, with market shares of 33% and 30%, respectively, in 2010. However, this trend is likely to change in the future as Asia Pacific is poised to grow faster than Europe and the US. Over the next five years, the Asia Pacific market is expected to grow by more than 10%, while Western European and the US markets will grow at 6% and 4%, respectively.
Increasing drug manufacturing activities in emerging nations is driving demand for packaging in countries such as India and China. These countries have emerged as favorite destinations for packaging companies, primarily due to lower wages, a skilled and plentiful workforce and the increasing availability of state-of-the-art technology. Also, demand for pharmaceutical packaging in these countries has increased, particularly in the wake of patent expiries, which allow these countries to emerge as centers for generic drug manufacturing. 


About This Report:

GBI Research’s new report, “Pharmaceutical Packaging Industry - 2011 Yearbook”,
provides insights into the global pharmaceutical packaging market, with coverage of the market landscape, key market trends, market drivers and restraints. The report provides market forecasts for the global pharmaceutical packaging industry until 2017. The geographical distribution of pharmaceutical packaging manufacturers across key geographies, such as the US, the top five countries in the European region, Japan and BRIC (Brazil, Russia, India and China) countries are also provided. Key cost and developmental issues are also addressed. The report provides an in-depth analysis of the competitive landscape, including the benchmarking of top companies, key trends on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging.

To purchase this report go to http://b2b.pharma-iq.com/event.cfm?eventID=228

Have Your Say
Rate this feature and give us your feedback in the comments section below


RECOMMENDED